|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-11-18 Sale |
2009-11-20 4:43 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | HealthCor Management, L.P. HealthCor Capital, L.P. HealthCor Associates, LLC HealthCor Group, LLC HEALTHCOR L P Cohen Arthur Bruce Healey Joseph Patrick (10% owner) | 3,000,000 | $32.25 | $96,750,000 | 7,000,000 (Indirect) | View |
| 2009-11-18 Sale |
2009-11-20 4:42 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | HealthCor Offshore GP, LLC HealthCor Hybrid Offshore GP, LLC HealthCor Hybrid Offshore Master Fund, L.P. HealthCor Offshore Master Fund, L.P. (10% owner) | 3,000,000 | $32.25 | $96,750,000 | 7,000,000 (Indirect) |
View |
| 2009-11-18 Purchase |
2009-11-19 1:50 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | CHAUDHURI BHASKAR (President) | 2,385 | $33.58 | $80,097 | 7,283 (Indirect) |
View |
| 2009-11-12 Purchase |
2009-11-12 7:53 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | Provencio Norma Ann (Director) | 1,000 | $33.25 | $33,250 | 38,908 (Direct) | View |
| 2009-11-10 Purchase |
2009-11-12 3:39 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | CHAUDHURI BHASKAR (President) | 1,525 | $32.81 | $50,039 | 4,898 (Indirect) |
View |
| 2009-11-04 Purchase | 2009-11-04 5:44 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | STEFANO STEPHEN F. (Director) | 1,635 | $30.82 | $50,391 | 13,118 (Direct) |
View |
| 2009-07-24- -2009-07-28 Purchase |
2009-07-28 5:05 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | ValueAct Holdings, L.P. ValueAct Capital Master Fund, L.P. VA Partners I, LLC ValueAct Capital Management, L.P. ValueAct Capital Management, LLC ValueAct Holdings GP, LLC (See remarks 10% owner) | 39,400 | $24.9 | $981,049 | 17,775,903 (Indirect) | View |
| 2009-05-15 Purchase | 2009-05-19 6:57 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | ValueAct Holdings, L.P. VA Partners I, LLC ValueAct Capital Management, L.P. ValueAct Capital Management, LLC ValueAct Holdings GP, LLC (See remarks below 10% owner) | 56,264 | $19.84 | $1,116,077 | 15,833,193 (Indirect) | View |
| 2008-10-29 Purchase | 2008-10-31 11:31 am | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | HealthCor Management, L.P. HealthCor Associates, LLC HealthCor Offshore, Ltd. HealthCor Hybrid Offshore HealthCor Group, LLC HealthCor Capital, L.P. HEALTHCOR L P Healey Joseph Patrick Cohen Arthur Bruce (10% owner) | 1,000,000 | $15.76 | $15,760,000 | 10,000,000 (Indirect) |
View |
| 2008-01-01 Sale |
2008-01-03 4:49 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | ULLIAN ELAINE (Director) | 7,707 | $0 | $0 | 0 (Direct) |
View |
| 2007-12-09 Sale |
2007-12-11 1:33 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | Wheeler Wesley (President, North America, R&D) | 35,000 | $0 | $0 | 3,446 (Direct) |
View |
| 2006-10-11- -2006-10-12 Purchase | 2006-10-13 5:02 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | VA PARTNERS LLC VA Partners III, LLC ValueAct Capital Management, L.P. ValueAct Capital Management, LLC UBBEN JEFFREY W KAMIN PETER H (10% owner) | 1,196,000 | $19.66 | $23,516,600 | 11,857,600 (Indirect) |
View |
| 2006-09-07- -2006-09-11 Purchase | 2006-09-11 5:12 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | VA PARTNERS LLC ValueAct Capital Management, L.P. ValueAct Capital Management, LLC UBBEN JEFFREY W KAMIN PETER H (10% owner) | 146,500 | $19.46 | $2,850,912 | 146,500 (Indirect) |
View |
| 2004-03-09 Sale |
2004-03-10 5:52 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | LEE STEVEN J (Director) | 11,000 | $25.7 | $282,739 | 0 (Direct Indirect) |
View |
| Transaction & Date | Reported Date | Company | Symbol | Insider Relationship | Shares Traded |
Average Price | Total Amount | Shares Ownership |
Filing |
| 2009-10-01 Option Award |
2009-10-05 6:25 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | STEFANO STEPHEN F. (Director) | 323 | $0 | $0 | 11,483 (Direct) |
View |
| 2009-10-01 Option Award |
2009-10-05 6:25 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | Provencio Norma Ann (Director) | 763 | $0 | $0 | 37,908 (Direct) | View |
| 2009-10-01 Option Award | 2009-10-05 6:25 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | MELAS KYRIAZI THEO (Director) | 346 | $0 | $0 | 43,575 (Direct) | View |
| 2009-10-01 Option Award |
2009-10-05 6:24 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | LONNER ANDERS (Director) | 602 | $0 | $0 | 8,881 (Direct) |
View |
| 2009-10-01 Option Award | 2009-10-05 6:24 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | KUGELMAN LARRY (Director) | 335 | $0 | $0 | 33,584 (Direct) |
View |
| 2009-10-01 Option Award | 2009-10-05 6:24 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | KOPPES RICHARD (Director) | 289 | $0 | $0 | 27,285 (Direct) | View |
| 2009-10-01 Option Award | 2009-10-05 6:24 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | INGRAM ROBERT ALEXANDER (Director) | 602 | $0 | $0 | 37,969 (Direct) | View |
| 2009-09-10 Option Award |
2009-09-14 2:58 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | DE SILVA RAJIV (Chief Operating Officer) | 9,007 | $0 | $0 | 107,638 (Direct) |
View |
| 2009-08-11 Tax Withholding | 2009-08-11 6:35 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | Min Steve T. (EVP and General Counsel) | 1,043 | $26.63 | $27,775 | 60,946 (Direct) |
View |
| 2009-07-27 Tax Withholding | 2009-07-29 6:13 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | Karlson Elisa A. (EVP & Chief Administrative) | 1,631 | $24.99 | $40,759 | 84,140 (Direct) | View |
| 2009-07-23 Tax Withholding | 2009-07-27 7:40 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | Pearson J. Michael (CEO and Chairman of the Board Director) | 34,803 | $24.73 | $860,678 | 1,224,913 (Direct) | View |
| 2009-05-12 Option Award |
2009-05-14 3:50 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | Morfit G Mason (Director) | 6,546 | $0 | $0 | 22,010 (Direct) |
View |
| 2009-03-16 Option Award |
2009-04-09 6:13 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | Blott Peter J (EVP & CFO) | 4,750 | $0 | $0 | 91,300 (Direct) | View |
| 2009-02-26 Other |
2009-03-02 3:37 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | ValueAct Holdings, L.P. VA Partners I, LLC VA Partners III, LLC ValueAct Capital Management, L.P. ValueAct Capital Management, LLC ValueAct Holdings GP, LLC (10% owner) | 2,151,400 | $17.53 | $37,714,042 | 13,241,300 (Indirect) | View |
| 2007-10-30 Option Award | 2007-11-01 6:08 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | PRUETTE EILEEN (EVP, General Counsel) | 25,000 | $14.8 | $370,000 | 26,446 (Direct) | View |
| 2007-10-30 Option Award |
2007-11-01 6:08 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | Bramlage Charles (President, Europe) | 25,000 | $14.8 | $370,000 | 25,000 (Direct) | View |
| 2007-10-30 Option Award |
2007-11-01 6:07 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | TYSON TIMOTHY (CEO and President Director) | 105,000 | $14.8 | $1,554,000 | 118,496 (Direct) |
View |
| 2006-08-31 Option Award | 2006-09-01 3:30 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BURKHARDT EDWARD A (Director) | 79 | $19.66 | $1,553 | 431 (Direct) |
View |
| 2006-08-02 Exercise | 2006-08-04 12:10 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | O LEARY ROBERT (Director) | 39,800 | $10.05 | $399,990 | 59,246 (Indirect) |
View |
| 2006-06-01 Option Award | 2006-06-05 4:50 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | LAMON KIM DAVID (Pres. & Chief Scientific Off.) | 44 | $17.61 | $775 | 140 (Direct) | View |
| 2006-06-01 Option Award | 2006-06-05 4:50 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | Cooper John (EVP, Global Manufac and Supply) | 44 | $17.61 | $775 | 140 (Direct) | View |
| 2006-06-01 Option Award |
2006-06-05 4:48 pm | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | THURMAN RANDY (Director) | 95 | $17.61 | $1,673 | 959 (Direct) |
View |
| 2006-06-01 Option Award |
2006-06-05 4:44 pm |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | Bramlage Charles (President, European Operations) | 44 | $17.61 | $775 | 140 (Direct) | View |
| 2003-08-20 Other |
2003-08-22 3:24 pm | RIBAPHARM INC | RNA | ICN PHARMACEUTICALS INC (10% owner) | 20,729,547 | $6.25 | $129,559,669 | 140,829,547 (Indirect) | View |
| Transaction & Date |
Reported Date | Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded |
Conversion Price | Shares Ownership |
Filing |
| 2008-10-29 Purchase |
2008-10-31 11:31 am | 2008-10-29 2008-11-22 |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | HealthCor Management, L.P. HealthCor Associates, LLC HealthCor Offshore, Ltd. HealthCor Hybrid Offshore HealthCor Group, LLC HealthCor Capital, L.P. HEALTHCOR L P Healey Joseph Patrick Cohen Arthur Bruce (10% owner) | 3,000 | $17.5 | 3,000 (Indirect) | View |
| 2007-10-30 Option Award |
2007-11-01 6:08 pm |
2008-10-30 2017-10-30 |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | PRUETTE EILEEN (EVP, General Counsel) | 6,756 | $14.8 | 6,756 (Direct) |
View |
| 2007-10-30 Option Award | 2007-11-01 6:08 pm | 2008-10-30 2017-10-30 |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | PRUETTE EILEEN (EVP, General Counsel) | 43,244 | $14.8 | 43,244 (Direct) | View |
| 2007-10-30 Option Award |
2007-11-01 6:08 pm |
2008-10-30 2017-10-30 |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | Bramlage Charles (President, Europe) | 6,756 | $14.8 | 6,756 (Direct) |
View |
| 2007-10-30 Option Award | 2007-11-01 6:08 pm | 2008-10-30 2017-10-30 | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | Bramlage Charles (President, Europe) | 43,244 | $14.8 | 43,244 (Direct) | View |
| 2007-10-30 Option Award | 2007-11-01 6:07 pm | 2008-10-30 2017-10-30 | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | TYSON TIMOTHY (CEO and President Director) | 6,756 | $14.8 | 6,756 (Direct) | View |
| 2007-10-30 Option Award |
2007-11-01 6:07 pm | 2008-10-30 2017-10-30 |
VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | TYSON TIMOTHY (CEO and President Director) | 203,244 | $14.8 | 203,244 (Direct) | View |
| 2006-10-31 Option Award | 2006-11-02 5:26 pm |
2007-10-31 2016-10-31 | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 5,353 | $18.68 | 5,353 (Direct) |
View |
| 2006-10-31 Option Award |
2006-11-02 5:26 pm |
2007-10-31 2016-10-31 | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | BAILEY BARY (EVP & CFO) | 94,647 | $18.68 | 94,647 (Direct) | View |
| 2006-08-02 Exercise | 2006-08-04 12:10 pm |
N/A 2012-08-01 | VALEANT PHARMACEUTICALS INTERNATIONAL | VRX | O LEARY ROBERT (Director) | 39,800 | $10.05 | 0 (Direct) |
View |
| 2003-11-04 Option Award |
2003-11-06 7:42 pm |
2004-11-04 2013-11-04 |
ICN PHARMACEUTICALS INC | ICN | DE VACA CHRISTINA (VP Corp Governance & Secretary) | 10,500 | $18.55 | 10,500 (Direct) |
View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 14:08:51 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |